Hyperglycemia inhibited phosphorylation of TET2 (a tumor suppressor), resulting in its destabilization, and dysregulation of its tumor suppressive activity and its substrate, 5-hydroxymethylcytosine (5hmC), in vitro as well as in vivo. Here, TET2 is linked to neoplasm.